Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
DNLI
PBLS
Add up to 3 more stocks
DNLI
Denali Therapeutics Inc.
-3.16%
$19.28-0.63Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$3.06B
52W Range
$13.75 - $27.30
PBLS
Parabilis Medicines, Inc.
-2.27%
$28.86-0.67Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$3.36B
52W Range
$20.00 - $42.49
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.66 | 3.21 |
| P/S Ratio | 849.04 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | -14191.2% | 0.0% |
| ROE | -61.2% | N/A |
| ROA | -44.2% | -180.5% |
| ROIC | -50.8% | -409.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 8.37 | 17.91 |
| Quick Ratio | 8.32 | 17.91 |
| Debt/Equity | 0.03 | 0.05 |
| Interest Coverage | N/A | -99.92 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.